Glitazone use associated with reduced risk of Parkinson's disease-Reference-Cited by-同舟云学术

Glitazone use associated with reduced risk of Parkinson's disease

Published:2017-09-01 Issue:11 Volume:32 Page:1594-1599
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Brakedal Brage¹²,Flønes Irene¹²,Reiter Simone F.¹²,Torkildsen Øivind¹²,Dölle Christian¹²,Assmus Jörg³,Haugarvoll Kristoffer¹²^ORCID,Tzoulis Charalampos¹²^ORCID

Affiliation:

1. Department of Neurology; Haukeland University Hospital; Bergen Norway

2. Department of Clinical Medicine; University of Bergen; Bergen Norway

3. Centre for Clinical Research; Haukeland University Hospital; Bergen Norway

Funder

Regional Health Authority of Western Norway

Research Council of Norway

Helse Vest

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference21 articles.

1. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group;Rijk;Neurology,2000

2. The prevalence of Parkinson's disease: a systematic review and meta-analysis;Pringsheim;Mov Disord,2014

3. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease;Breidert;J Neurochem,2002

4. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation;Dehmer;J Neurochem,2004

5. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease;Schintu;Eur J Neurosci,2009

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-diabetic drug use and reduced risk of Parkinson's disease: A community-based cohort study;Parkinsonism & Related Disorders;2024-11

2. Metformin Attenuates Manganese-Induced Oxidative Stress in N27-A Dopaminergic Neuronal Cells;Biological and Pharmaceutical Bulletin;2024-02-28

3. PPAR agonists for the treatment of neuroinflammatory diseases;Trends in Pharmacological Sciences;2024-01

4. Synergizing drug repurposing and target identification for neurodegenerative diseases;Progress in Molecular Biology and Translational Science;2024

5. Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson’s disease in diabetic patients;Scientific Reports;2023-12-15